-
Product Directory
Custom Product
-
Services Offered
Custom Capabilities
-
|
|
||||||
|
On this page:
Through the powerful science of RNA interference, successful gene silencing can be achieved with the use of synthetic, small interfering RNA (siRNA). By targeting these small, synthetic oligos, typically 19-23 bases in length against a specific gene of interest researchers are identifying gene function, elucidating pathways, and screening for potential new drug targets. Features
New siRNA Features FAST siRNAs Unpurified siRNA is as effective as purified siRNA For successful knockdown of your gene of interest, order our siRNA (small interfering RNA) oligos. Our unpurified siRNA oligos are as effective in reducing gene expression as purified siRNA oligos in cell culture experiments, making them very cost effective. All our siRNA oligos are deprotected, desalted and ready-to-use. For siRNA usage in animal models please see our MISSION® In Vivo Quality and iScale Oligos™ siRNA website. Superior Manufacturing Capacity With a capacity to synthesize over one million siRNA oligos per year, Sigma offers reliable delivery times, no matter how many oligonucleotides you order. RNA Chemistry and Proprietary Technologies of Sigma Our RNA synthesis relies on the use of fast deprotection ribonucleoside phosphoramidites protected at the 2' position by a tert-butyldimethylsilyl (TBDMS) group and, at the 3' position, by a phosphoramidite. RNA synthesis and deprotection are performed using Sigma's proprietary technologies ie. Ultra Fast Parallel Synthesis (UFPS) and Ultra Fast Parallel Deprotection (UFPD). The use of these technologies means higher coupling efficiency and faster deprotection, resulting in higher quality synthesis and faster turn-around times. Specifications of siRNA Oligos Related Products MISSION siRNA Human Druggable Genome MISSION siRNA Rat Druggable Genome MISSION siRNA Mouse Kinase Library siRNA Literature for Download Sales Brochure (626 Kb PDF) siRNA Users Guide by Tuschl et al. |
|
||||
|
|
||||||